NEWS
BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114
• The study, led by Dr. Lopa Mishra and published in Cell Reports, provides new mechanistic evidence for role of BF-114 target β2-spectrin in obesity, MASLD, MASH, and HCC
• The findings suggest that targeting β2-spectrin with BF-114 can prevent the progression of liver diseases
• New data builds on earlier studies and further supports BF-114's potential to address major unmet needs in treating obesity-related liver diseases
• Dr. Lopa Mishra, a globally recognized expert in liver disease, has joined BullFrog AI's Scientific Advisory Board to provide strategic insights for advancing BF-114
• The findings suggest that targeting β2-spectrin with BF-114 can prevent the progression of liver diseases
• New data builds on earlier studies and further supports BF-114's potential to address major unmet needs in treating obesity-related liver diseases
• Dr. Lopa Mishra, a globally recognized expert in liver disease, has joined BullFrog AI's Scientific Advisory Board to provide strategic insights for advancing BF-114
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2492Followers
107Following
27KVisitors
Follow